Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2026 Jan 14.
doi: 10.1038/s41698-025-01204-0. Online ahead of print.

Targeted immunotherapies and nanomedicines for ovarian cancer: the way forward

Yue Li  1   2 , Juntong Dou  1   2 , Yannan Fu  1   2 , Xiao Ma  1   2 , Yang Yang  1   2 , Zhenhua Lin  3   4
Affiliations
Free article
Review

Targeted immunotherapies and nanomedicines for ovarian cancer: the way forward

Yue Li et al. NPJ Precis Oncol. .
Free article

Abstract

Ovarian cancer (OC) is the leading cause of death among gynecological cancers, with high mortality due to late diagnosis. Immunotherapy and nanomedicine show potential in targeting cancer cells and inducing immunogenic cell death. However, challenges like poor biodegradability and untargeted immune activation persist. Emerging solutions, including enhanced nanoparticles and personalized medicine, aim to improve efficacy while minimizing side effects by tailoring treatments to individual profiles and disease stages.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Feng, X. et al. Prognostic impact of hepatitis B virus infection in patients with primary cervical cancer. Cancer Med. 10, 8310–8309 (2021).
    1. Chang, C. Y. et al. Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan. BMC Women’s. Health 21, 274 (2021).
    1. Wang, G. et al. Development and clinical validation of a seven-gene signature based on tumor stem cell-related genes to predict ovarian cancer prognosis. J. Ovarian Res. 17, 58 (2024).
    1. Kvale, E. et al. Survivorship Care for Women Living With Ovarian Cancer: Protocol for a Randomized Controlled Trial. JMIR Res. Protoc. 13, e48069 (2024).
    1. Guo, Y. et al. Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies. J. Mater. Chem. B 11, 8586–8604 (2023).

LinkOut - more resources